Last checked at 25 Feb 2021 13:02
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Said Darwazah |
2 | Reason for the notification | |
a) | Position/status | Executive Chairman |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Grant of a pledge by Darhold Limited over 1,345,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J.P. Morgan (Suisse) SA. Darhold Limited is defined as a Person Closely Associated with the Executive Chairman, who is a director and shareholder of Darhold. |
c) | Price(s) and volume(s) | Price(s): £0.00p Volume(s): 1,345,000 |
d) | Aggregated information | Aggregated volume: 1,345,000 Price: £0.00p |
e) | Date of the transaction | 23 February 2021 |
f) | Place of the transaction | Amman |
Mazen Darwazah
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Mazen Darwazah |
2 | Reason for the notification | |
a) | Position/status | Executive Vice Chairman |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Grant of a pledge by Darhold Limited over 1,345,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J.P. Morgan (Suisse) SA. Darhold Limited is defined as a Person Closely Associated with the Executive Vice Chairman, who is a director and shareholder of Darhold. |
c) | Price(s) and volume(s) | Price(s): £0.00p Volume(s): 1,345,000 |
d) | Aggregated information | Aggregated volume: 1,345,000 Price: £0.00p |
e) | Date of the transaction | 23 February 2021 |
f) | Place of the transaction | Amman |
Mohammed 'Ali' Al-Husry
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Mohammed 'Ali' Al-Husry |
2 | Reason for the notification | |
a) | Position/status | Non-Executive Director |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Grant of a pledge by Darhold Limited over 1,345,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J.P. Morgan (Suisse) SA. Darhold Limited is defined as a Person Closely Associated with the Non-Executive Director, who is a director and shareholder of Darhold. |
c) | Price(s) and volume(s) | Price(s): £0.00p Volume(s): 1,345,000 |
d) | Aggregated information | Aggregated volume: 1,345,000 Price: £0.00p |
e) | Date of the transaction | 23 February 2021 |
f) | Place of the transaction | Amman |
Peter SpeirsCompany Secretary, responsible for releasing this announcement+44 (0) 20 7399 2760